I am an asthmatic, like millions of other Americans, and need a rescue inhaler. The propellant that used to be in these inhalers, CFC, was very effective in sending the medicine deep into the lungs. In the early 2000s, GlaxoSmithKline saw their opportunity, and lobbied Congress to make CFCs in inhalers illegal, because they had developed a proprietary alternative, and far inferior, propellant, HFA. Not only is this propellant insufficient to deliver medication deep into the lungs, and in fact causes clogging of the inhaler which was never before a problem, but generic rescue inhalers disappeared overnight, sending the price of an inhaler from around $5 to over $50, and in some cases hundreds of dollars. Millions of asthmatics lungs, and pockets, are suffering…all so Glaxo could make an extra buck. Our ‘democracy’ at work.
Ellen, New Hampshire